Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.

Dysplastic nodules with glypican-3 positive immunostaining: a risk for early hepatocellular carcinoma.

Glypican-3 (GPC3) has been reported to be a novel serum and histochemical marker for HCC. The positivity or negativity for GPC3 in hepatic precancerous lesions, such as dysplastic nodules (DN), has also been described. Moreover, our previous studies have demonstrated that some DN in liver cirrhosis...

Full description

Bibliographic Details
Main Authors: Li Gong, Long-Xiao Wei, Pin Ren, Wen-Dong Zhang, Xiao-Yan Liu, Xiu-Juan Han, Li Yao, Shao-Jun Zhu, Miao Lan, Yan-Hong Li, Wei Zhang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3909016?pdf=render

Similar Items

Similar Items